2026 NPPES data Cardiovascular Disease Physician NPI 1225195233 MD
Verify on CMS →

MARK MILCHAK, MD

Cardiovascular Disease Physician in LATROBE, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 516 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
80%
generic claims · 20% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.4K
14 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK MILCHAK, MD filed 3,055 Medicare Part D claims in 2023 as a Cardiovascular Disease Physician in LATROBE, Pennsylvania, prescribing 80% generic.

3K
Part D claims, 2023
80%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK MILCHAK, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

3,055 Top 11% higher than 89% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MARK MILCHAK, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK MILCHAK, MD?

Quality data not reported

NPI registry status

Active

Issued 01/02/2007

NPI 1225195233

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

3,055 1% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

Specialty distribution in Pennsylvania

How Cardiovascular Disease Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Cardiovascular Disease Physician share within Pennsylvania

1. Cardiovascular Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cardiovascular Disease Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Cardiovascular Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Cardiovascular Disease Physician ABMS/AOA estimate

Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK MILCHAK, MD appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding MD credentials at 100 EXCELA HEALTH DR STE 203, LATROBE, PA, 15650, with a listed phone of (724) 539-6320. NPI 1225195233 was issued on 01/02/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MILCHAK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,055 prescription claims written by this provider, covering 516 Medicare beneficiaries and totaling roughly $620K in drug spend, split 20% brand-name and 80% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

100 EXCELA HEALTH DR STE 203
LATROBE, PA 15650

Provider Details

NPI 1225195233
Specialty Cardiovascular Disease Physician
Credentials MD
Gender Male
NPI Issued 01/02/2007

Hospital and facility affiliations

Facilities where MARK MILCHAK, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EXCELA HEALTH PHYSICIAN PRACTICES, INC
LATROBE, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK MILCHAK, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.4K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to MARK MILCHAK, MD. To verify MARK MILCHAK, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MARK MILCHAK, MD — brand share 20.0%
Specialty average (est.)

20% brand-name claims vs 80% generic, on 3,055 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,055
Total Claims
$620K
Total Drug Cost
516
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,354
Total Day Supply
219,429
Brand vs Generic
20% brand / 80% generic
Brand Drug Cost
$555K
Generic Drug Cost
$65K
Antibiotic Claims
11

Patient Demographics

Average Patient Age
75.8 years
Avg HCC Risk Score
1.40
Gender Split
50% female / 50% male
Age Distribution
<65: 29, 65-74: 195, 75-84: 214, 85+: 78

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK MILCHAK, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Rosuvastatin Calcium
344
Xarelto
Rivaroxaban
285
Atorvastatin Calcium
231
Lisinopril
224
Metoprolol Succinate
213
Carvedilol
177
Ezetimibe
156
Amlodipine Besylate
155
Eliquis
Apixaban
144
Metoprolol Tartrate
109

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How MARK MILCHAK, MD fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

MARK MILCHAK, MD's 3,055 claims are above the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as MILCHAK.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK MILCHAK, MD's specialty?
MARK MILCHAK, MD specializes in Cardiovascular Disease Physician and practices in LATROBE, Pennsylvania. Credentials: MD.
How much does MARK MILCHAK, MD prescribe under Medicare Part D?
In 2023, MARK MILCHAK, MD wrote 3,055 Medicare Part D claims totaling $620K in drug costs for 516 beneficiaries.
Where is MARK MILCHAK, MD located?
MARK MILCHAK, MD is located at 100 EXCELA HEALTH DR STE 203, LATROBE, PA, 15650. Phone: (724) 539-6320.
What is MARK MILCHAK, MD's NPI number?
MARK MILCHAK, MD's National Provider Identifier (NPI) is 1225195233, issued on 01/02/2007.
Does MARK MILCHAK, MD prescribe more brand-name or generic drugs?
MARK MILCHAK, MD's prescribing is 20% brand-name and 80% generic drugs by claim count, with $555K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does MARK MILCHAK, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK MILCHAK, MD's most frequently prescribed drugs include Rosuvastatin Calcium, Xarelto, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK MILCHAK, MD accept Medicare?
MARK MILCHAK, MD appears in CMS Medicare data with 3,055 Part D claims and 516 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK MILCHAK, MD's credentials?
MARK MILCHAK, MD's NPI is 1225195233 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology